Drug recall · October 31, 2018
Bumetanide Tablets recall
Why: Failed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bumetanide Tablets, USP, 1 mg, 100-count bottle, Rx only, Manufactured by: Upser-Smith Laboratories, LLC, Maple Grove, MN 55369, NDC 0832-0541-11
- Lots / codes
Lot#: 375716, Exp 4/30/2020; 372957, 372958, 372959, Exp 3/31/2020; 374541, 375717, 376688, Exp 5/31/2020
- Quantity
- 44,764 bottles
- Company
- Upsher Smith Laboratories, Inc., Maple Grove, MN
- Distribution
- Nationwide USA, Puerto Rico and Guam
- Initiated
- September 19, 2018 · Voluntary: Firm initiated
- Classified
- November 21, 2018
- Reported
- October 31, 2018
- Ended
- September 30, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bumetanide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.